Electromed, Inc. Names John Kowalczyk Vice President of Sales

NEW PRAGUE, Minn.--(BUSINESS WIRE)--

Electromed, Inc. (NYSE MKT: ELMD), maker of the SmartVest® Airway Clearance System, today announced that John Kowalczyk has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives. Along with medical sales leadership, growing product lines, and the success of building new businesses, Kowalczyk brings to Electromed an outlook of promoting a culture of learning, improvement, and executing best practices.

"John has a proven track record of leading and developing high performing sales teams that deliver sustainable growth and profit. In addition, he has consistently created winning and positive cultures that reward achievement, engender loyalty, and celebrate success," said Kathleen Skarvan, President and Chief Executive Officer.

Kowalczyk previously served as Vice President of Sales at Medtronic, Inc. in the areas of pain stimulation and target drug delivery, neuromodulation, gastroenterology, and urology. Most recently, he served as President of DorsaVi, an Australia-based company commercializing products for the elite sports, occupational health and safety, and medical physiotherapy markets. Kowalczyk holds a Bachelor of Arts Degree in International Relations from the University of Wisconsin, Madison. He will report to Skarvan.

About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota and founded in 1992. Further information about the Company can be found at www.smartvest.com.

Electromed, Inc.
Kathleen Skarvan, 952-758-9299
President and Chief Executive Officer
kskarvan@electromed.com

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!